United Therapeutics
UTHR
#1022
Rank
S$28.85 B
Marketcap
S$637.92
Share price
1.12%
Change (1 day)
31.16%
Change (1 year)

EPS for United Therapeutics (UTHR)

EPS in 2025 (TTM): S$37.50

According to United Therapeutics's latest financial reports the company's current EPS (TTM) is S$36.82. In 2024 the company made an earnings per share (EPS) of S$34.16 an increase over its 2023 EPS that were of S$27.20.

EPS history for United Therapeutics from 2013 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S$37.509.78%
2024S$34.1625.59%
2023S$27.2031.54%
2022S$20.6751.18%
2021S$13.68-9.1%
2020S$15.04-581.4%
2019S-$3.13-117.79%
2018S$17.5642.11%
2017S$12.36-40.93%
2016S$20.9213.45%
2015S$18.44104.29%
2014S$9.03100.29%
2013S$4.51

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Eli Lilly
LLY
S$26.50-28.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
S$8.42-77.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$0.81-97.79%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Pfizer
PFE
S$2.22-93.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
S-$0.85-102.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
S-$8.12-122.06%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
S$4.64-87.39%๐Ÿ‡ฌ๐Ÿ‡ง UK
Cardinal Health
CAH
S$8.60-76.64%๐Ÿ‡บ๐Ÿ‡ธ USA